National pharmacovigilance program

Indian Pediatrics

Volumn 43, Issue 1, 2006, Pages 27-32

  Bavdekar, Sandeep B ^a,b   Karande, Sunil ^a  

^a KEM HOSPITAL   (India)

^b CHS ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD HEALTH; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE MANAGEMENT; HEALTH PRACTITIONER; HEALTH SERVICE; INDIA; INFORMATION DISSEMINATION; MEDICOLEGAL ASPECT; NURSE; ORGANIZATION; PEDIATRICS; PHARMACIST; PRIVACY; SHORT SURVEY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG MONITORING; HUMANS; INDIA; NATIONAL HEALTH PROGRAMS; PRODUCT SURVEILLANCE, POSTMARKETING; PROGRAM DEVELOPMENT; PROGRAM EVALUATION;

EID: 32644432693     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. World Health Organization Collaborating Center for International Drug Monitoring. The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva: World Health Organization, 2002.
2. World Health Organization Collaborating Center for International Drug Monitoring. Geneva: World Health Organization. 1984, WHO publication DEM/NC/84.153 (E).
3. WHO. Safety of Medicines. A guide to detecting and reporting adverse drug reactions. Why health professionals need to take action. Geneva, World Health Organization, 2002. WHO/EDM/QSM/2002.2
4. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in pediatric in/outpatients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
5. WHO. Safety of Medicines. A Guide to detecting and reporting adverse reactions. Why health professionals need to take action. WHO/EDM/QSM/2002.2
6. Karan RS, Malhotra S, Pandhi P. The drug lag: New drugs introduction in India in comparison to United States. J Assoc Physicians India 2002; 50: 782-787.
7. Kshirsagar NA, Karande S, Potkar CN. Adverse drug reaction monitoring in India. J Assoc Physicians India 1993; 41: 474-476.
8. Lele RD. Ayurveda (ancient Indian system of medicine) and modern molecular medicine. J Assoc Physicians India 1999; 47: 625-628.
9. Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA. The use and safety of non-allopathic Indian Medicines. Drug Safety 2002; 25: 1015-1019.
10. Gogtay NJ, Dalvi SS, Kshirsagar NA. Safety monitoring: An Indian Perspective. Int J Risk Safety Med 2003; 16: 21-30.